NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.
Hanaoka
Nobuyoshi
N
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Jabri
Bana
B
Dai
Zhenpeng
Z
Ciszewski
Cezary
C
Stevens
Anne M
AM
Yee
Cassian
C
Nakakuma
Hideki
H
Spies
Thomas
T
Groh
Veronika
V